ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)

ClearPoint Neuro's (CLPT) quarterly Short-term Investments came in at $9.9 million in Q1 2023, little changed quarter-over-quarter from $9.9 million in Q4 2022.

ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023) Analysis & Trends

ClearPoint Neuro has disclosed Short-term Investments across 2 years of filings, most recently posting $9.9 million for Q1 2023.

  • Short-term Investments for Q1 2023 came in at $9.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $9.9 million (changed N/A YoY), and the FY2022 annual result was $9.9 million, changed N/A from the prior year.
  • Short-term Investments came in at $9.9 million for Q1 2023 at ClearPoint Neuro, roughly flat from $9.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $21.7 million in Q3 2022 to a low of $9.9 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 ClearPoint Neuro 524.46 Mn 488.86 Mn 7.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2023 9.94 Mn
Dec 31, 2022 9.90 Mn
Sep 30, 2022 21.75 Mn
Jun 30, 2022 21.60 Mn